A top military doctor revealed on Sunday that the Pentagon has developed a microchip that, when introduced into the human body, can detect COVID-19.
What are the details?
Dr. Matt Hepburn, a retired army colonel and infectious disease physician, told CBS, the Advanced Defense Research Projects Agency, a secret military unit set up during the Cold War, for “60 Minutes.” subdermal ”to prevent pandemic diseases. from debilitating military resources.
COVID-19, for example, managed to remove the USS Theodore Roosevelt – one of the critical aircraft carriers of the US Navy – for almost two months last spring, when almost 1,300 sailors tested positive for COVID.
The device, according to CBS News, is not “a government-feared microchip that tracks your every move, but a tissue-like gel designed to continuously test your blood.”
Hepburn compared the technology to an “engine control light.”
“It’s a sensor,” he explained. “The little green thing over there, you put it under your skin and what it tells you is that there are chemical reactions in your body and that the signal means you will have symptoms tomorrow.”
Therefore, the device allows military personnel to find out their infection status before they start infecting others.
“The sailors received the signal, then self-administered the blood draw and tested themselves on the spot. We can have this information in three to five minutes,” Hepburn said. “As you truncate that time, as you diagnose and treat it, what you do is stop the infection in its wake.”
A sensor that can tell you if you are sick
www.youtube.com
How many soldiers have the “sensor”?
Hepburn did not provide further details about the so-called “sensor” beyond explaining its basic functionality and saying that the device “is now in late testing”.
It is not clear how many US soldiers walk with the device.
And while active duty soldiers may have no choice but to receive the microchip if the Pentagon gives it the green light, there would certainly be widespread reluctance to receive the device.
In fact, American soldiers are even reluctant to receive the COVID-19 vaccine.
The military has said publicly that a third of soldiers choose not to receive the vaccine, although CNN reported, citing military sources, that the true percentage could be closer to half.
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
window.REBELMOUSE_STDLIB.loadExternalScript("https://assets.revcontent.com/master/delivery.js", function() {
});
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
//Facebook Pixel Code !function(f,b,e,v,n,t,s) {if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)}(window, document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1398069580413568'); fbq('track', 'PageView');
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
function menuClick() { console.log("clicked");
if (document.querySelector('.hambg-btn.js--active') != null) { document.getElementsByClassName('huge-menu')[0].style.display = 'none'; document.getElementsByClassName('hambg-btn')[0].classList.remove('js--active'); document.body.classList.remove("huge-menu-opened"); document.body.classList.remove("menu-opened"); } else{ document.getElementsByClassName('huge-menu')[0].style.display = 'block'; document.getElementsByClassName('hambg-btn')[0].classList.add('js--active'); document.body.classList.add("huge-menu-opened"); document.body.classList.remove("menu-opened"); } }
function addMenuClickListener() { var rebelMenu = document.getElementsByClassName('rebelbar__menu-toggle'); var menuClose = document.getElementsByClassName('hm__close'); var stickyMenu = document.getElementsByClassName('sticky-menu');
rebelMenu[0].addEventListener('click', menuClick);
if(menuClose[0] != undefined){ menuClose[0].addEventListener('click', menuClick);}
if(stickyMenu[0] != undefined){ stickyMenu[0].addEventListener('click', menuClick); } }
addMenuClickListener();
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
window.REBELMOUSE_STDLIB.loadExternalScript("https://assets.adobedtm.com/98de9919e92a38033805f9f035c43198533e4380/satelliteLib-38c7b1e4b1bb3e0378e82d10601662aebfb04eda.js", function() {
window.analyticsData = { events: {active: {view: {asset: {}}, device: {}}} }; window.analyticsData.events.active.device.appVersion = "1.1"; window.analyticsData.events.active.device.host = "premiere.off.us"; window.analyticsData.events.active.device.subHost = "theblaze.com"; window.analyticsData.events.active.pageName = "articles"; //window.analyticsData.events.active.view.asset.id = "articles|"+ __BOOTSTRAP__.post.basename; window.analyticsData.events.active.view.asset.name = document.title; //window.analyticsData.events.active.view.authorId = __BOOTSTRAP__.post.original_user_subsite.title; window.analyticsData.events.active.view.pubDate = "04/13/2021"; window.analyticsData.events.active.view.contentOriginType = "Premiere"; window.analyticsData.events.active.view.stationCallLetter = "TheBlaze"; window.analyticsData.events.active.view.stationFormat = "NEWSTALK"; window.analyticsData.events.active.view.stationMarket = "PREMIERE"; window.analyticsData.events.active.view.personalityId = "theBlaze"; window.analyticsData.events.active.view.tags = ["microchip", "covid-19", "covid", "dr-matt-hepburn", "60-minutes", "us-military"]; window.analyticsData.events.active.view.photoGalleryExists = "FALSE"; window.analyticsData.events.active.view.photoGalleryPageView = "FALSE"; window.analyticsData.events.active.view.contentFrame = "page"; window._satellite && _satellite.pageBottom();
});
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
function test_adblock(func, id) { var t="0.1.2-dev", el = document.createElement('div'); el.id = id ? id : 'sponsorText'; el.appendChild(document.createTextNode(' ')); Object.assign(el.style, { left: '-999px', position: 'absolute' }); document.body.appendChild(el); setTimeout(function() { if (el) { var o = el.clientHeight === 0; func(o, t); document.body.removeChild(el); } }, 200); } test_adblock(function(is_blocked) { console.log(is_blocked); var wid = is_blocked ? 140286 : 140117, target = document.getElementById('rc-adblock-widget'); var el = document.createElement('div'); el.setAttribute('data-rc-widget', ''); el.setAttribute('data-endpoint', 'trends.revcontent.com'); el.setAttribute('data-widget-id', wid); target.appendChild(el); if (typeof window.renderRCWidget !== 'function') { var script = document.createElement('script'); script.src="https://assets.revcontent.com/master/delivery.js"; script.defer = true; target.appendChild(script); } else { window.renderRCWidget(el) } });
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
(function(s,u,m,o,j,v){j=u.createElement(m);v=u.getElementsByTagName(m)[0];j.async=1;j.src=o;j.dataset.sumoSiteId='f20bb26e74a94a53daa9113206b98941e1dfba90635d317b9efd9e33a89bf515';v.parentNode.insertBefore(j,v)})(window,document,'script','//load.sumo.com/');
}); .Source